NIPT for Patau Syndrome in Nepal — Trisomy 13 Screening Cell-free DNA screening for trisomy 13 from 10 weeks of pregnancy
NIPT for Patau syndrome (trisomy 13) screens maternal blood for extra chromosome 13 material from 10 weeks of pregnancy — highly accurate, non-invasive, and available in Kathmandu.
Medically Reviewed Content
Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Last medical review: November 8, 2026
Next scheduled review: May 8, 2027
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
Important Safety Information
- NIPT is a screening test, not diagnostic — positive results require CVS or amniocentesis for confirmation.
- Do not make decisions based on NIPT alone — await diagnostic confirmation.
- Diagnostic procedures (CVS, amniocentesis) carry ~0.5–1% miscarriage risk — discuss with genetic counsellor.
- NIPT cannot detect all genetic conditions — a low-risk result does not guarantee a healthy pregnancy.
- Always inform your obstetrician of NIPT results for integrated pregnancy care.
Prenatal Genetic Screening in Kathmandu and Nepal
- Emerging availability — NIPT is increasingly available in Kathmandu private facilities; access outside major cities remains limited.
- Maternal age factor — Advanced maternal age increases chromosomal abnormality risk; NIPT is particularly relevant for women over 35.
- Cost considerations — NIPT costs in Nepal are higher than traditional screening but lower than overseas options; packages may be available.
- Diagnostic follow-up — Positive NIPT requires CVS or amniocentesis for confirmation; these procedures are available in major Nepali hospitals.
- Cultural context — Prenatal testing decisions in Nepal often involve family consultation; genetic counselling supports informed choices.
- Healthcare integration — NIPT complements but does not replace standard antenatal care — ultrasound, blood tests, and clinical assessment remain essential.
NIPT and Patau Syndrome: What You Need to Know
Patau syndrome, also called trisomy 13, is a chromosomal disorder caused by having three copies of chromosome 13 instead of the usual two. It is one of the most severe chromosomal abnormalities — most affected pregnancies result in miscarriage, stillbirth, or death shortly after birth. For the rare survivors, severe intellectual disability and multiple congenital anomalies are universal. Because of its severity, prenatal detection is important for informed decision-making.
Non-invasive prenatal testing (NIPT) screens maternal blood for cell-free fetal DNA to detect chromosomal abnormalities including trisomy 13. NIPT can be performed from 10 weeks of pregnancy — earlier than many traditional screening methods — and has high detection rates for trisomy 13, though slightly lower sensitivity than for trisomy 21 (Down syndrome).
It is critical to understand that NIPT is a screening test, not a diagnostic test. A positive result indicates increased risk but requires confirmation through diagnostic testing — chorionic villus sampling (CVS) or amniocentesis — before any clinical decisions are made. NIPT also has limitations: it cannot detect all cases, may give false positives or false negatives, and does not screen for all genetic conditions.
This guide explains how NIPT detects trisomy 13, its accuracy and limitations, who should consider testing, what results mean, how diagnostic confirmation works, and how Thamel Clinic provides NIPT services in Kathmandu.
How NIPT Detects Trisomy 13
NIPT analyses cell-free DNA (cfDNA) in maternal blood. During pregnancy, the placenta releases small fragments of fetal DNA into the maternal bloodstream — these fragments comprise a mixture of maternal and fetal genetic material. By analysing the proportion of DNA from each chromosome, NIPT can detect abnormalities in chromosome number.
For trisomy 13 detection, the test measures the relative amount of chromosome 13 material. If the fetus has three copies of chromosome 13, there is excess chromosome 13 DNA in the maternal blood compared to expected levels. Statistical analysis of chromosome representation across millions of DNA fragments identifies this imbalance.
NIPT can be performed from 10 weeks of pregnancy because sufficient fetal cfDNA must be present for accurate analysis. Earlier testing may fail due to inadequate fetal fraction — the proportion of fetal vs maternal DNA. Factors affecting fetal fraction include maternal weight, gestational age, and certain medical conditions.
- Analyses cell-free fetal DNA in maternal blood.
- Detects excess chromosome 13 material indicating trisomy 13.
- Available from 10 weeks of pregnancy.
- Requires sufficient fetal fraction — affected by maternal weight and gestational age.
- Screens for multiple conditions simultaneously including trisomy 13, 18, 21.
Cell-Free DNA Analysis
Fetal DNA fragments in maternal blood analysed for chromosome abnormalities.
Trisomy 13 Detection
Excess chromosome 13 material identified through statistical analysis.
Early Testing
Available from 10 weeks — earlier than many traditional screening methods.
Multi-Condition Screening
Single blood draw screens for trisomies 13, 18, 21 and sex chromosome abnormalities.
Accuracy, Sensitivity, and Limitations
NIPT has high sensitivity and specificity for trisomy 13, though slightly lower than for trisomy 21. Detection rates for trisomy 13 are typically above 90 percent with false positive rates below 0.1 percent in most studies — however, performance varies by test platform and patient characteristics.
Critical limitations must be understood. NIPT is a screening test, not diagnostic — positive results require confirmation through CVS or amniocentesis. False positives can occur due to confined placental mosaicism, maternal chromosomal abnormalities, or vanishing twin syndrome. False negatives can occur if fetal fraction is insufficient or technical factors affect analysis.
NIPT does not detect all genetic conditions — it screens for specific chromosomal abnormalities but cannot identify single-gene disorders, structural chromosomal rearrangements, or open neural tube defects. It also cannot determine the severity of findings or predict outcomes for affected pregnancies.
- Sensitivity for trisomy 13: typically >90%; false positive rate <0.1%.
- Screening test, not diagnostic — positive requires CVS or amniocentesis.
- False positives: confined placental mosaicism, maternal issues, vanishing twin.
- False negatives: insufficient fetal fraction or technical factors.
- Does not detect single-gene disorders, structural rearrangements, or neural tube defects.
High Accuracy
Sensitivity >90% and false positive rate <0.1% for trisomy 13 in most platforms.
Screening Not Diagnostic
Positive results require invasive confirmation before clinical decisions.
False Results Possible
Mosaicism, maternal factors, and technical issues can cause false positives/negatives.
Limited Scope
Screens specific trisomies only — not all genetic conditions.
Who Should Consider NIPT for Patau Syndrome
NIPT is generally offered to all pregnant women as an option, but is particularly relevant for those at increased risk of chromosomal abnormalities. Advanced maternal age — typically 35 or older — significantly increases the risk of trisomy 13 and other chromosomal conditions, making NIPT particularly valuable.
Women with abnormal first-trimester screening results — increased nuchal translucency on ultrasound, abnormal serum markers — should consider NIPT as a follow-up screening option. Those with a previous pregnancy affected by chromosomal abnormality also have elevated risk.
It is important to understand that NIPT is optional — not mandatory. Some women choose NIPT for reassurance, others prefer diagnostic testing directly, and some decline genetic screening entirely. The decision should be informed, voluntary, and made in consultation with healthcare providers and genetic counsellors.
- Advanced maternal age (35+) — significantly increased chromosomal risk.
- Abnormal first-trimester screening — nuchal translucency or serum markers.
- Previous chromosomal abnormality in pregnancy.
- Available to all pregnant women as an option.
- Decision should be informed and voluntary.
Advanced Maternal Age
Women 35+ have significantly higher risk of trisomy 13 and benefit most from screening.
Abnormal Screening
Increased nuchal translucency or serum markers warrant further evaluation.
Previous Affected Pregnancy
History of chromosomal abnormality increases recurrence risk.
Optional Testing
NIPT is a choice — informed decision-making with genetic counselling recommended.
Understanding Results and Diagnostic Confirmation
NIPT results typically report as low risk, high risk, or no result. Low risk indicates the fetus is unlikely to have trisomy 13. High risk indicates increased probability — requiring diagnostic confirmation. No result may occur due to insufficient fetal fraction or technical issues, and repeat testing or alternative approaches may be needed.
A high-risk NIPT result does NOT diagnose trisomy 13 — it indicates increased probability requiring confirmation. Diagnostic confirmation is performed through chorionic villus sampling (CVS) at 11–14 weeks or amniocentesis after 15 weeks. Both procedures carry a small risk of miscarriage (typically 0.5–1%) and provide definitive chromosomal analysis.
Genetic counselling is essential both before testing — to understand implications, limitations, and options — and after results — to interpret findings, discuss options, and support decision-making. Decisions about continuing or terminating affected pregnancies are deeply personal and should be made with full information and support.
- Results: low risk, high risk, or no result (insufficient fetal fraction).
- High risk = increased probability, NOT diagnosis — requires confirmation.
- Confirmation: CVS at 11–14 weeks or amniocentesis after 15 weeks.
- Diagnostic procedures carry ~0.5–1% miscarriage risk.
- Genetic counselling essential before and after testing.
Result Categories
Low risk, high risk, or no result — each has specific implications.
High Risk ≠ Diagnosis
Positive screening requires CVS or amniocentesis for definitive diagnosis.
Diagnostic Options
CVS at 11–14 weeks or amniocentesis after 15 weeks — definitive but invasive.
Genetic Counselling
Essential before testing and after results for informed decision-making.
NIPT Services and Pricing in Nepal
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| NIPT Basic Panel | Trisomies 21, 18, 13 screening from maternal blood. | Rs. 45,000–65,000 |
| NIPT Extended Panel | Trisomies plus sex chromosome abnormalities and microdeletions. | Rs. 65,000–95,000 |
| NIPT Plus Panel | Comprehensive panel including rare autosomal trisomies. | Rs. 85,000–1,20,000 |
| Genetic Counselling Session | Pre-test and post-test counselling for informed decision-making. | Rs. 1,500–3,000 |
| First-Trimester Screening | Nuchal translucency ultrasound + serum markers (alternative/complement). | Rs. 8,000–15,000 |
| Obstetric Ultrasound | Anomaly scan and pregnancy monitoring. | Rs. 2,000–5,000 |
| Diagnostic Referral | Coordination for CVS or amniocentesis at partner facilities. | Referral |
Prices are indicative and may vary by panel and laboratory; confirm current rates when booking.
Why Choose Thamel Clinic for NIPT
- Comprehensive NIPT panels — Basic, extended, and plus options covering trisomy 13 and other conditions.
- Genetic counselling — Pre-test and post-test counselling for informed decision-making.
- Accurate reporting — Clear result interpretation with clinical context and next steps.
- Diagnostic coordination — Referral support for CVS/amniocentesis confirmation when needed.
- Integrated care — NIPT complements obstetric care at the same facility.
- Confidential service — Private genetic testing with discreet handling of sensitive information.
- Transparent pricing — Clear costs for testing, counselling, and follow-up services.
Frequently Asked Questions
What is NIPT for Patau syndrome?
NIPT screens maternal blood for cell-free fetal DNA to detect trisomy 13 — having three copies of chromosome 13. It is a screening test from 10 weeks of pregnancy, not diagnostic.
How accurate is NIPT for trisomy 13?
NIPT has sensitivity >90% and false positive rate <0.1% for trisomy 13 in most studies. However, it is a screening test — positive results require diagnostic confirmation through CVS or amniocentesis.
When can I do NIPT for trisomy 13?
NIPT can be performed from 10 weeks of pregnancy. Earlier testing may fail due to insufficient fetal DNA. Accurate dating by ultrasound is recommended before testing.
What does a high-risk NIPT result mean?
High risk indicates increased probability of trisomy 13 — NOT a diagnosis. Diagnostic confirmation through CVS (11–14 weeks) or amniocentesis (after 15 weeks) is required before clinical decisions.
What is Patau syndrome?
Patau syndrome (trisomy 13) is a chromosomal disorder caused by three copies of chromosome 13. It is severe — most affected pregnancies result in miscarriage, stillbirth, or death shortly after birth. Survivors have severe intellectual disability and multiple anomalies.
Do I need NIPT if I am under 35?
NIPT is optional for all pregnant women. While risk is lower under 35, it is not zero. Some women choose NIPT for reassurance; others prefer diagnostic testing or decline screening.
What if my NIPT result is "no result"?
No result typically means insufficient fetal fraction — often due to early gestation or higher maternal weight. Repeat testing after a few weeks or alternative screening may be recommended.
How much does NIPT cost in Kathmandu?
NIPT panels typically cost Rs. 45,000–1,20,000 depending on the panel type. Basic trisomy screening is at the lower end; extended panels with microdeletions cost more. Genetic counselling is additional Rs. 1,500–3,000.
Is NIPT covered by insurance in Nepal?
Coverage varies by insurer. Some Nepali health insurance plans include prenatal genetic testing benefits. Contact your insurer or Thamel Clinic to verify your specific coverage.
What are the alternatives to NIPT?
First-trimester combined screening (nuchal translucency + serum markers), second-trimester quadruple screening, and diagnostic testing (CVS/amniocentesis). Each has different accuracy, timing, and invasiveness trade-offs.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
NIPT in Nepal
Complete guide to NIPT testing in Nepal.
NIPT for Down Syndrome
NIPT screening for trisomy 21.
NIPT for Edwards Syndrome
NIPT screening for trisomy 18.
NIPT Eligibility
Who should consider NIPT and when.
Understanding NIPT Results
Interpreting low risk, high risk, and no result.
NIPT FAQ
Common questions about NIPT answered.
Prenatal Genetic Testing
Complete prenatal genetic screening services.
Book an Appointment
Schedule NIPT and genetic counselling.
Related Health Guides
Medical Review & Sources
Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)
Role: Prenatal genetic screening and obstetric reviewers, Thamel Clinic, Kathmandu
Last reviewed: 2026-11-08
Reviewed against current clinical guidelines. This is general medical information; a registered clinician must assess each patient before treatment.
Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered